Cargando…
Safety and tolerability of lacosamide monotherapy in the elderly: A subgroup analysis from lacosamide trials in diabetic neuropathic pain
OBJECTIVE: To assess the safety profile of lacosamide monotherapy in elderly (≥65 years) subjects with diabetic neuropathic pain (DNP). METHODS: Of 1,863 DNP subjects in double‐blind, randomized, placebo‐controlled trials of lacosamide monotherapy (NCT00861445, NCT00235469, NCT00238524, NCT00135109,...
Autores principales: | Bainbridge, Jacquelyn, De Backer, Marc, Eckhardt, Klaus, Tennigkeit, Frank, Bongardt, Sabine, Sen, David, Werhahn, Konrad J., Shaibani, Aziz, Faught, Edward |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862116/ https://www.ncbi.nlm.nih.gov/pubmed/29588972 http://dx.doi.org/10.1002/epi4.12079 |
Ejemplares similares
-
Effects of lacosamide and carbamazepine on lipids in a randomized trial
por: Mintzer, Scott, et al.
Publicado: (2020) -
Long‐term safety and efficacy of lacosamide and controlled‐release carbamazepine monotherapy in patients with newly diagnosed epilepsy
por: Ben‐Menachem, Elinor, et al.
Publicado: (2019) -
Changes in drug load during lacosamide combination therapy: A noninterventional, observational study in German and Austrian clinical practice
por: Reinhardt, Fritjof, et al.
Publicado: (2019) -
Efficacy and Safety of Lacosamide in Painful Diabetic Neuropathy
por: Ziegler, Dan, et al.
Publicado: (2010) -
Genomic and clinical predictors of lacosamide response in refractory epilepsies
por: Heavin, Sinéad B., et al.
Publicado: (2019)